Literature DB >> 26791779

Hypoxia-induced alterations of G2 checkpoint regulators.

Grete Hasvold1, Christin Lund-Andersen1, Malin Lando1, Sebastian Patzke1, Sissel Hauge1, ZhenHe Suo2, Heidi Lyng1, Randi G Syljuåsen3.   

Abstract

Hypoxia promotes an aggressive tumor phenotype with increased genomic instability, partially due to downregulation of DNA repair pathways. However, genome stability is also surveilled by cell cycle checkpoints. An important issue is therefore whether hypoxia also can influence the DNA damage-induced cell cycle checkpoints. Here, we show that hypoxia (24 h 0.2% O2) alters the expression of several G2 checkpoint regulators, as examined by microarray gene expression analysis and immunoblotting of U2OS cells. While some of the changes reflected hypoxia-induced inhibition of cell cycle progression, the levels of several G2 checkpoint regulators, in particular Cyclin B, were reduced in G2 phase cells after hypoxic exposure, as shown by flow cytometric barcoding analysis of individual cells. These effects were accompanied by decreased phosphorylation of a Cyclin dependent kinase (CDK) target in G2 phase cells after hypoxia, suggesting decreased CDK activity. Furthermore, cells pre-exposed to hypoxia showed increased G2 checkpoint arrest upon treatment with ionizing radiation. Similar results were found following other hypoxic conditions (∼0.03% O2 20 h and 0.2% O2 72 h). These results demonstrate that the DNA damage-induced G2 checkpoint can be altered as a consequence of hypoxia, and we propose that such alterations may influence the genome stability of hypoxic tumors.
Copyright © 2016 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DNA damage; G2 checkpoint; Genome stability; Hypoxia; Ionizing radiation

Mesh:

Year:  2016        PMID: 26791779      PMCID: PMC5423158          DOI: 10.1016/j.molonc.2015.12.015

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  65 in total

1.  Pathways of DNA double-strand break repair during the mammalian cell cycle.

Authors:  Kai Rothkamm; Ines Krüger; Larry H Thompson; Markus Löbrich
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

2.  Defect in multiple cell cycle checkpoints in ataxia-telangiectasia postirradiation.

Authors:  H Beamish; R Williams; P Chen; M F Lavin
Journal:  J Biol Chem       Date:  1996-08-23       Impact factor: 5.157

Review 3.  Regulatory roles of cyclin dependent kinase phosphorylation in cell cycle control.

Authors:  D J Lew; S Kornbluth
Journal:  Curr Opin Cell Biol       Date:  1996-12       Impact factor: 8.382

4.  Regulation of cyclin B2 expression and cell cycle G2/m transition by menin.

Authors:  Ting Wu; Xiuli Zhang; Xiaohua Huang; Yuqing Yang; Xianxin Hua
Journal:  J Biol Chem       Date:  2010-04-19       Impact factor: 5.157

5.  Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells.

Authors:  Alice X Meng; Farid Jalali; Andrew Cuddihy; Norman Chan; Ranjit S Bindra; Peter M Glazer; Robert G Bristow
Journal:  Radiother Oncol       Date:  2005-08       Impact factor: 6.280

6.  Adaptation to the ionizing radiation-induced G2 checkpoint occurs in human cells and depends on checkpoint kinase 1 and Polo-like kinase 1 kinases.

Authors:  Randi G Syljuåsen; Sanne Jensen; Jiri Bartek; Jiri Lukas
Journal:  Cancer Res       Date:  2006-11-01       Impact factor: 12.701

7.  Conservative homologous recombination preferentially repairs DNA double-strand breaks in the S phase of the cell cycle in human cells.

Authors:  Nasrollah Saleh-Gohari; Thomas Helleday
Journal:  Nucleic Acids Res       Date:  2004-07-13       Impact factor: 16.971

8.  Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery.

Authors:  Libor Macůrek; Arne Lindqvist; Dan Lim; Michael A Lampson; Rob Klompmaker; Raimundo Freire; Christophe Clouin; Stephen S Taylor; Michael B Yaffe; René H Medema
Journal:  Nature       Date:  2008-07-09       Impact factor: 49.962

Review 9.  Hypoxia signalling through mTOR and the unfolded protein response in cancer.

Authors:  Bradly G Wouters; Marianne Koritzinsky
Journal:  Nat Rev Cancer       Date:  2008-10-10       Impact factor: 60.716

10.  Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells.

Authors:  Ranjit S Bindra; Paul J Schaffer; Alice Meng; Jennifer Woo; Kårstein Måseide; Matt E Roth; Paul Lizardi; David W Hedley; Robert G Bristow; Peter M Glazer
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

View more
  10 in total

Review 1.  Inside the hypoxic tumour: reprogramming of the DDR and radioresistance.

Authors:  Katheryn Begg; Mahvash Tavassoli
Journal:  Cell Death Discov       Date:  2020-08-18

2.  Moving Forward in Cervical Cancer: Enhancing Susceptibility to DNA Repair Inhibition and Damage, an NCI Clinical Trials Planning Meeting Report.

Authors:  Matthew M Harkenrider; Merry Jennifer Markham; Don S Dizon; Anuja Jhingran; Ritu Salani; Ramy K Serour; Jean Lynn; Elise C Kohn
Journal:  J Natl Cancer Inst       Date:  2020-11-01       Impact factor: 13.506

3.  Hypoxia-induced alterations of G2 checkpoint regulators.

Authors:  Grete Hasvold; Christin Lund-Andersen; Malin Lando; Sebastian Patzke; Sissel Hauge; ZhenHe Suo; Heidi Lyng; Randi G Syljuåsen
Journal:  Mol Oncol       Date:  2016-01-08       Impact factor: 6.603

Review 4.  The importance of hypoxia in radiotherapy for the immune response, metastatic potential and FLASH-RT.

Authors:  Eui Jung Moon; Kristoffer Petersson; Monica M Olcina
Journal:  Int J Radiat Biol       Date:  2021-11-02       Impact factor: 2.694

5.  Hypoxia modulates the stem cell population and induces EMT in the MCF-10A breast epithelial cell line.

Authors:  Carl S Daly; Arwa Flemban; Mai Shafei; Myra E Conway; David Qualtrough; Sarah J Dean
Journal:  Oncol Rep       Date:  2017-12-01       Impact factor: 3.906

6.  Combined inhibition of Wee1 and Chk1 gives synergistic DNA damage in S-phase due to distinct regulation of CDK activity and CDC45 loading.

Authors:  Sissel Hauge; Christian Naucke; Grete Hasvold; Mrinal Joel; Gro Elise Rødland; Petras Juzenas; Trond Stokke; Randi G Syljuåsen
Journal:  Oncotarget       Date:  2017-02-14

Review 7.  Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management.

Authors:  Renata Rodrigues da Cunha Colombo Bonadio; Rodrigo Nogueira Fogace; Vanessa Costa Miranda; Maria Del Pilar Estevez Diz
Journal:  Clinics (Sao Paulo)       Date:  2018-08-20       Impact factor: 2.365

8.  p21 limits S phase DNA damage caused by the Wee1 inhibitor MK1775.

Authors:  Sissel Hauge; Libor Macurek; Randi G Syljuåsen
Journal:  Cell Cycle       Date:  2019-04-03       Impact factor: 4.534

Review 9.  Inside the hypoxic tumour: reprogramming of the DDR and radioresistance.

Authors:  Katheryn Begg; Mahvash Tavassoli
Journal:  Cell Death Discov       Date:  2020-08-18

10.  Rhein, a novel Histone Deacetylase (HDAC) inhibitor with antifibrotic potency in human myocardial fibrosis.

Authors:  Jorg Kotzka; Birgit Knebel; David Monteiro Barbosa; Pia Fahlbusch; Daniella Herzfeld de Wiza; Sylvia Jacob; Ulrike Kettel; Hadi Al-Hasani; Martina Krüger; D Margriet Ouwens; Sonja Hartwig; Stefan Lehr
Journal:  Sci Rep       Date:  2020-03-17       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.